Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GSK343 |
| Trade Name | |
| Synonyms | GSK-343|GSK 343 |
| Drug Descriptions |
GSK343 is an inhibitor of EZH2, which decreases tri-methylation of H3K27, potentially resulting in decreased growth and increased apoptosis of tumor cells (PMID: 23759589, PMID: 31791385). |
| DrugClasses | EZH2 inhibitor 20 |
| CAS Registry Number | 1346704-33-3 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Dasatinib + GSK343 | Dasatinib GSK343 | 0 | 0 |
| GSK343 | GSK343 | 0 | 0 |
| GSK343 + MK2206 | GSK343 MK2206 | 0 | 0 |
| GSK343 + Selumetinib | GSK343 Selumetinib | 0 | 0 |